Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Regulatory News


Director/PDMR Shareholding

Thu, 7th Dec 2017 16:28


RNS Number : 7445Y
Genedrive PLC
07 December 2017

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has granted share options ("Options") to certain of its directors and senior management to acquire a total of 156,087 ordinary shares of 1.5p each in the capital of the Company under the Company's newly adopted 2017 Share Option Scheme.

The Options have been granted with an exercise price equal to the close price on the day before grant and vest after a period of three years. The Options will vest after 3 years only if certain performance criteria are met. The Options are exercisable over the period of 10 years from the date of grant.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Gordon Powell

2. Gino Miele

3. Nancy Neilson

2.

Reason for the notification

a.

Position/status

1. Commercial Director

2. R&D Director

3. Quality Assurance Director

a.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

genedrive plc

b.

LEI

213800ZYODIRZ87Y4K14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Options over ordinary shares of 1.5 pence each

b.

Nature of the transaction

Grant of options pursuant to and in accordance with the terms of the Company's Share Option Scheme dated 29 November 2017.

c.

Price(s) and volume(s)

Price(s)

Option price(s)

Volume(s)

Gordon Powell

36.0p

88,063

Gino Miele

36.0p

43,024

Nancy Neilson

36.0p

25,000

d.

Aggregated information

Aggregated volume

Price

N/A

e.

Date of the transaction

2017-12-07; UTC time

f.

Place of the transaction

Outside trading venue - shares to be admitted to AIM market of London Stock Exchange plc on exercise of options

For further details please contact:

genedrive plc

+44 (0)161 989 0245

David Budd: CEO


Matthew Fowler: CFO


Peel Hunt LLP

+44 (0)207 418 8900

James Steel


Oliver Jackson


Consilium Strategic Communications

+44 (0)203 709 5700

Chris Gardner


Matthew Neal


Laura Thornton


genedrive@consilium-comms.com



This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAKAXEAKXFFF


Related Shares:
Genedrive (GDR)



Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.